4ouo
From Proteopedia
(Difference between revisions)
| (5 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | {{STRUCTURE_4ouo| PDB=4ouo | SCENE= }} | ||
| - | ===anti-Bla g 1 scFv=== | ||
| - | {{ABSTRACT_PUBMED_24667070}} | ||
| - | == | + | ==anti-Bla g 1 scFv== |
| - | [[4ouo]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OUO OCA]. | + | <StructureSection load='4ouo' size='340' side='right'caption='[[4ouo]], [[Resolution|resolution]] 1.80Å' scene=''> |
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4ouo]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OUO OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4OUO FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.8Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ouo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ouo OCA], [https://pdbe.org/4ouo PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ouo RCSB], [https://www.ebi.ac.uk/pdbsum/4ouo PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ouo ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Bla g 1 is a major allergen from Blatella germanica and one of the primary allergens used to assess cockroach allergen exposure. The epitope of an anti-Bla g 1 scFv was mapped in order to better understand cross reactivity with other group 1 cockroach allergens and patient IgE epitopes. X-ray crystallography was used to determine the structure of the scFv. The scFv epitope on Bla g 1 was located by alanine scanning site-directed mutagenesis and ELISA. Twenty-six rBla g 1-GST alanine mutants were evaluated for variations in binding to the scFv compared to the wild type allergen. Six mutants showed a significant difference in scFv binding affinity. These mutations clustered to form a discontinuous epitope mainly comprising two helices of Bla g 1. The allergen-scFv complex was modeled based on the results, and the epitope region was found to have low sequence similarity with Per a 1, especially among the residues identified as functionally important for the scFv binding to Bla g 1. Indeed, the scFv failed to bind Per a 1 in American cockroach extract. The scFv was unable to inhibit the binding of IgE antibodies from a highly cockroach allergic patient to Bla g 1. Based on the surface area of Bla g 1 occluded by the scFv, putative regions of patient IgE-Bla g 1 interactions can be inferred. This scFv could be best utilized as a capture antibody in an IgE detection ELISA, or to differentiate Bla g 1 from Per a 1 in environmental exposure assays. | ||
| - | + | Characterization of an anti-Bla g 1 scFv: Epitope mapping and cross-reactivity.,Mueller GA, Ankney JA, Glesner J, Khurana T, Edwards LL, Pedersen LC, Perera L, Slater JE, Pomes A, London RE Mol Immunol. 2014 Jun;59(2):200-7. doi: 10.1016/j.molimm.2014.02.003. Epub 2014, Mar 22. PMID:24667070<ref>PMID:24667070</ref> | |
| - | <ref | + | |
| - | [[ | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
| - | [[ | + | </div> |
| - | [[ | + | <div class="pdbe-citations 4ouo" style="background-color:#fffaf0;"></div> |
| - | [[Category: | + | |
| - | [[Category: | + | ==See Also== |
| - | [[Category: | + | *[[Antibody 3D structures|Antibody 3D structures]] |
| - | [[Category: | + | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] |
| - | [[Category: | + | *[[3D structures of non-human antibody|3D structures of non-human antibody]] |
| - | [[Category: | + | == References == |
| - | [[Category: | + | <references/> |
| - | [[Category: | + | __TOC__ |
| - | [[Category: | + | </StructureSection> |
| - | [[Category: | + | [[Category: Gallus gallus]] |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Ankney JA]] |
| + | [[Category: Edwards LL]] | ||
| + | [[Category: Glesner J]] | ||
| + | [[Category: Khurana T]] | ||
| + | [[Category: London RE]] | ||
| + | [[Category: Mueller GA]] | ||
| + | [[Category: Pedersen LC]] | ||
| + | [[Category: Perera L]] | ||
| + | [[Category: Pomes A]] | ||
| + | [[Category: Slater JE]] | ||
Current revision
anti-Bla g 1 scFv
| |||||||||||
Categories: Gallus gallus | Large Structures | Ankney JA | Edwards LL | Glesner J | Khurana T | London RE | Mueller GA | Pedersen LC | Perera L | Pomes A | Slater JE
